CSS
TXMD icon

Cubist Systematic Strategies’s TherapeuticsMD TXMD Stock Holding History

Cubist Systematic Strategies’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-714
Closed -$7K – 4732
2022
Q2 		$7K Buy
714
+693
+3,300% +$6.62K ﹤0.01% 4286
2022
Q1 		$0 Buy
21
+3
+17% +$47 ﹤0.01% 3781
2021
Q4 		$0 Sell
18
-9,447
-100% -$283K ﹤0.01% 3642
2021
Q3 		$351K Buy
+9,465
New +$420K ﹤0.01% 2258
2021
Q2 		– Sell
-8,789
Closed -$589K – 3115
2021
Q1 		$589K Buy
8,789
+8,488
+2,820% +$664K 0.01% 1869
2020
Q4 		$18K Buy
+301
New +$20.6K ﹤0.01% 2507
2020
Q3 		– Sell
-1,700
Closed -$106K – 2648
2020
Q2 		$106K Buy
1,700
+1,117
+192% +$65K ﹤0.01% 2183
2020
Q1 		$31K Sell
583
-517
-47% -$51.3K ﹤0.01% 2043
2019
Q4 		$133K Buy
1,100
+84
+8% +$12.1K ﹤0.01% 2134
2019
Q3 		$184K Sell
1,016
-518
-34% -$73K ﹤0.01% 1806
2019
Q2 		$199K Sell
1,534
-217
-12% -$38.9K ﹤0.01% 2056
2019
Q1 		$426K Buy
+1,751
New +$463K 0.01% 1289
2018
Q2 		– Sell
-842
Closed -$205K – 2062
2018
Q1 		$205K Buy
+842
New +$236K 0.01% 1387
2017
Q4 		– Sell
-207
Closed -$55K – 2095
2017
Q3 		$55K Buy
+207
New +$59.8K ﹤0.01% 1722
2017
Q2 		– Sell
-262
Closed -$94K – 1889
2017
Q1 		$94K Buy
262
+172
+191% +$53.2K 0.01% 1408
2016
Q4 		$26K Buy
+90
New +$27.9K ﹤0.01% 1626
2016
Q2 		– Sell
-556
Closed -$178K – 1888
2016
Q1 		$178K Buy
+556
New +$190K 0.01% 1260
2015
Q3 		– Sell
-2,226
Closed -$875K – 2027
2015
Q2 		$875K Buy
+2,226
New +$785K 0.04% 652

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Cubist Systematic Strategies's TXMD Position: Q3 2022 in Review

Cubist Systematic Strategies sold out of TherapeuticsMD (TXMD) in Q3 2022, closing a stake of 714 shares — an estimated $7K sold.

Cubist Systematic Strategies first reported a position in TXMD in Q2 2015 and held it in 18 quarters. The position peaked at $875K in Q2 2015. 43 funds tracked by Wall St. Rank hold TXMD as of Q3 2022.

  • Cubist Systematic Strategies reported no remaining TherapeuticsMD position as of Q3 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 714 TherapeuticsMD shares in Q3 2022, an estimated $7K.
  • Cubist Systematic Strategies first reported a position in TherapeuticsMD in Q2 2015 and held it in 18 quarters.
  • Cubist Systematic Strategies's TherapeuticsMD position peaked at $875K in Q2 2015.
  • 43 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2022.

Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.